Literature DB >> 9852564

Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway.

S L Ingram1, C W Vaughan, E E Bagley, M Connor, M J Christie.   

Abstract

Chronic morphine administration induces adaptations in neurons resulting in opioid tolerance and dependence. Functional studies have implicated a role for the periaqueductal gray area (PAG) in the expression of many signs of opioid withdrawal, but the cellular mechanisms are not fully understood. This study describes an increased efficacy, rather than tolerance, of opioid agonists at mu-receptors on GABAergic (but not glutamatergic) nerve terminals in PAG after chronic morphine treatment. Opioid withdrawal enhanced the amplitudes of electrically evoked inhibitory synaptic currents mediated by GABAA receptors and increased the frequency of spontaneous miniature GABAergic synaptic currents. These effects were not blocked by 4-aminopyridine or dendrotoxin, although both Kv channel blockers abolish acute opioid presynaptic inhibition of GABA release in PAG. Instead, the withdrawal-induced increases were blocked by protein kinase A inhibitors and occluded by metabolically stable cAMP analogs, which do not prevent acute opioid actions. These findings indicate that opioid dependence induces efficacious coupling of mu-receptors to presynaptic inhibition in GABAergic nerve terminals via adenylyl cyclase- and protein kinase A-dependent processes in PAG. The potential role of these adaptations in expression of withdrawal behavior was supported by inhibition of enhanced GABAergic synaptic transmission by the alpha2 adrenoceptor agonist clonidine. These findings provide a cellular mechanism that is consistent with other studies demonstrating attenuated opioid withdrawal behavior after injections of protein kinase A inhibitors into PAG and suggest a general mechanism whereby opioid withdrawal may enhance synaptic neurotransmission.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9852564      PMCID: PMC6793345     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  42 in total

1.  Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance.

Authors:  S K Sharma; W A Klee; M Nirenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

Review 2.  Neurotransmitters in nociceptive modulatory circuits.

Authors:  H L Fields; M M Heinricher; P Mason
Journal:  Annu Rev Neurosci       Date:  1991       Impact factor: 12.449

3.  Increased opioid inhibition of GABA release in nucleus accumbens during morphine withdrawal.

Authors:  B Chieng; J T Williams
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

4.  Direct modulation of the secretory machinery underlies PKA-dependent synaptic facilitation in hippocampal neurons.

Authors:  L E Trudeau; D G Emery; P G Haydon
Journal:  Neuron       Date:  1996-10       Impact factor: 17.173

5.  Increased probability of GABA release during withdrawal from morphine.

Authors:  A Bonci; J T Williams
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

6.  Brain sites of precipitated abstinence in morphine-dependent rats.

Authors:  E Wei; H H Loh; E L Way
Journal:  J Pharmacol Exp Ther       Date:  1973-04       Impact factor: 4.030

7.  Anatomically distinct opiate receptor fields mediate reward and physical dependence.

Authors:  M A Bozarth; R A Wise
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

8.  Protein kinases in the locus coeruleus and periaqueductal gray matter are involved in the expression of opiate withdrawal.

Authors:  R Maldonado; O Valverde; C Garbay; B P Roques
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-11       Impact factor: 3.000

9.  Opioid inhibition of rat periaqueductal grey neurones with identified projections to rostral ventromedial medulla in vitro.

Authors:  P B Osborne; C W Vaughan; H I Wilson; M J Christie
Journal:  J Physiol       Date:  1996-01-15       Impact factor: 5.182

10.  A demonstration of naloxone-precipitated opiate withdrawal on single neurones in the morphine-tolerant/dependent rat brain.

Authors:  J P Fry; A Herz; W Zieglgänsberger
Journal:  Br J Pharmacol       Date:  1980-03       Impact factor: 8.739

View more
  70 in total

1.  Augmented responses to morphine and cocaine in mice with a 12-lipoxygenase gene disruption.

Authors:  Carrie L Walters; Bao-Cheng Wang; Misty Godfrey; Duxin Sun; Colin D Funk; Julie A Blendy
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

2.  How to design an opioid drug that causes reduced tolerance and dependence.

Authors:  Amy Chang Berger; Jennifer L Whistler
Journal:  Ann Neurol       Date:  2010-05       Impact factor: 10.422

3.  Neuroadaptation of GABAergic transmission in the central amygdala during chronic morphine treatment.

Authors:  Michal Bajo; Marisa Roberto; Samuel G Madamba; George Robert Siggins
Journal:  Addict Biol       Date:  2010-12-23       Impact factor: 4.280

Review 4.  Mu-opioid receptor desensitization: is morphine different?

Authors:  Mark Connor; Peregrine B Osborne; MacDonald J Christie
Journal:  Br J Pharmacol       Date:  2004-10-25       Impact factor: 8.739

5.  Shadows across mu-Star? Constitutively active mu-opioid receptors revisited.

Authors:  Mark Connor
Journal:  Br J Pharmacol       Date:  2009-04       Impact factor: 8.739

Review 6.  Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

Authors:  John T Williams; Susan L Ingram; Graeme Henderson; Charles Chavkin; Mark von Zastrow; Stefan Schulz; Thomas Koch; Christopher J Evans; Macdonald J Christie
Journal:  Pharmacol Rev       Date:  2013-01-15       Impact factor: 25.468

7.  Neonatal morphine administration leads to changes in hippocampal BDNF levels and antioxidant enzyme activity in the adult life of rats.

Authors:  J R Rozisky; G Laste; I C de Macedo; V S Santos; R Krolow; C Noschang; C Vanzella; K Bertoldi; G A Lovatel; I C C de Souza; I R Siqueira; C Dalmaz; W Caumo; I L S Torres
Journal:  Neurochem Res       Date:  2012-12-09       Impact factor: 3.996

8.  Noradrenaline triggers GABAA inhibition of bed nucleus of the stria terminalis neurons projecting to the ventral tegmental area.

Authors:  Eric C Dumont; John T Williams
Journal:  J Neurosci       Date:  2004-09-22       Impact factor: 6.167

9.  Morphine-induced receptor endocytosis in a novel knockin mouse reduces tolerance and dependence.

Authors:  Joseph A Kim; Selena Bartlett; Li He; Carsten K Nielsen; Amy M Chang; Viktor Kharazia; Maria Waldhoer; Chrissi J Ou; Stacy Taylor; Madeline Ferwerda; Dragana Cado; Jennifer L Whistler
Journal:  Curr Biol       Date:  2008-01-22       Impact factor: 10.834

10.  A single in vivo exposure to cocaine abolishes endocannabinoid-mediated long-term depression in the nucleus accumbens.

Authors:  Lawrence Fourgeaud; Susana Mato; Delphine Bouchet; Agnès Hémar; Paul F Worley; Olivier J Manzoni
Journal:  J Neurosci       Date:  2004-08-04       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.